The average one-year price target for Mind Medicine (NasdaqGS:MNMD) has been revised to $29.15 / share. This is an increase of 11.49% from the prior estimate of $26.15 dated December 18, 2025. The ...
Mind Medicine (MindMed) MNMD is developing its lead pipeline candidate MM120, an orally disintegrating tablet (ODT) and a pharmaceutically optimized form of lysergide D-tartrate, for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results